




A 44-year-old healthy, active man presented to an
outside hospital complaining of a 1-day history of fever up
to 39C, muscle aches, sinus pressure, nausea, vomiting,
and diarrhea in April 2015. Review of systems was negative
for abdominal pain, hematochezia, or melena. A chest
radiograph was negative for infiltration, consolidation,
edema, or other pathology. Lipase level was 37 U/L (within
normal limits). A nasopharyngeal swab antigen test was
positive for influenza B, and the patient was discharged on
oseltamivir. Three days later, intermittent fevers persisted
with chills, nausea, vomiting, and severe abdominal pain.
Anorexia developed, and the patient described “something
twisting and pulling at [his] insides.” An abdominal
computed tomography scan showed extensive superior
mesenteric vein thrombosis, which extended into the main
portal vein and proximal splenic vein. He was transferred to
our facility for transhepatic thrombolysis, which was com-
plicated by intrahepatic hematoma requiring subselective
hepatic artery embolization. He recovered completely and
was discharged with rivaroxaban. Hematology evaluation
was negative for predisposing hypercoagulable conditions
including factor II mutation, factor V Leiden, and lupus
anticoagulant. Of note, his past medical, surgical, and family
history were unrevealing for malignancy, coagulopathy,
cirrhosis, pancreatitis, or other prothrombotic states.
Infection is not prominent among etiologies of acute
mesenteric venous thrombosis, but any local inflammation
may be predisposing.1 One case of influenza A with coin-
cident mesenteric venous thrombosis has been reported,
although the patient also had protein S deficiency.2 Epide-
miologic data have indicated that prior infection is a risk
factor for venous thromboembolism,3 and studies with
vascular devices have shown that infectious and thrombotic
complications may coincide.4 Interestingly, influenzaFunding: None.
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confirmed, as a contributing, if not causative, factor in
thrombotic events.5,6
Recent research in influenza pathogenesis offers potential
links between influenza infection and thrombosis. Highly
pathogenic avian influenza infects endothelial cells, pro-
moting vascular pathology in some species, but evidence of
direct human endothelial cells infection is lacking.7 How-
ever, endothelial activation may be indirect. In ferrets,
influenza infection causes increased D-dimer levels, von
Willebrand factor activity, prothrombin time, and intravas-
cular thrombin deposition. These findings have been more
pronounced in pandemic H1N1 and highly pathogenic avian
influenza H5N1, compared with seasonal H3N2.8 Influenza
may further promote thrombosis and vascular disease by
inducing cytokines such as interleukin-6, interleukin-1b,
and tumor necrosis factor-a, signals known to activate
endothelial cells and platelets and modulate macrophage
survival.7
Perhaps underappreciated, Influenza B accounts for a
substantial portion of influenza infections in the US.9 It
accounted for 13.5% of influenza admissions and the
majority of influenza cases occurring after mid-March during
the 2014-2015 season at our institution. Although there is
similar mortality among hospitalized influenza A- and
B-infected adults, there are many fewer clinical and
epidemiologic data regarding influenza B and its compli-
cations.9,10 While its virology and host tropism make a
pandemic unlikely, Influenza B can be responsible for a
high proportion of incidence, morbidity, and cost of total
influenza illness.9
Although this patient with a complicated course of
Influenza B infection had a favorable outcome, this case
illustrates the increasingly appreciated clinical pearl that
Influenza B can be as pathogenic as Influenza A. Further
epidemiologic and basic research may discern the rela-
tionship between influenza infection and pathologic
vascular events. Finally, clinicians should bear in mind that
patients with any strain of influenza, including seemingly
mild cases, may still suffer complications of thromboem-
bolic disease, which can be effectively treated when
diagnosed promptly.ACKNOWLEDGMENT
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